Circulating tumor DNA quantity is related to tumor volume and both predict survival in metastatic pancreatic ductal adenocarcinoma

Circulating tumor DNA (ctDNA) is assumed to reflect tumor burden and has been suggested as a tool for prognostication and follow‐up in patients with metastatic pancreatic ductal adenocarcinoma (mPDAC). However, the prognostic value of ctDNA and its relation with tumor burden has yet to be substantia...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Int J Cancer
Main Authors: Strijker, Marin, Soer, Eline C., de Pastena, Matteo, Creemers, Aafke, Balduzzi, Alberto, Beagan, Jamie J., Busch, Olivier R., van Delden, Otto M., Halfwerk, Hans, van Hooft, Jeanin E., van Lienden, Krijn P., Marchegiani, Giovanni, Meijer, Sybren L., van Noesel, Carel J., Reinten, Roy J., Roos, Eva, Schokker, Sandor, Verheij, Joanne, van de Vijver, Marc J., Waasdorp, Cynthia, Wilmink, Johanna W., Ylstra, Bauke, Besselink, Marc G., Bijlsma, Maarten F., Dijk, Frederike, van Laarhoven, Hanneke W.
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley & Sons, Inc. 2019
Assuntos:
Tumor Markers and Signatures
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7004068/
https://ncbi.nlm.nih.gov/pubmed/31340061
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ijc.32586
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados